List of Tables
Table 1. Global VMAT2 Inhibitor Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global VMAT2 Inhibitor Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global VMAT2 Inhibitor Market Competitive Situation by Manufacturers in 2025
Table 4. Global VMAT2 Inhibitor Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global VMAT2 Inhibitor Sales Market Share by Manufacturers (2021–2026)
Table 6. Global VMAT2 Inhibitor Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global VMAT2 Inhibitor Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market VMAT2 Inhibitor Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of VMAT2 Inhibitor, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of VMAT2 Inhibitor, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of VMAT2 Inhibitor, Product Types and Applications
Table 12. Global Key Manufacturers of VMAT2 Inhibitor, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global VMAT2 Inhibitor Companies by Tier (Tier 1, Tier 2, Tier 3), based on VMAT2 Inhibitor Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global VMAT2 Inhibitor Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global VMAT2 Inhibitor Sales by Region (K Units), 2021–2026
Table 18. Global VMAT2 Inhibitor Sales Market Share by Region (2021–2026)
Table 19. Global VMAT2 Inhibitor Sales by Region (K Units), 2027–2032
Table 20. Global VMAT2 Inhibitor Sales Market Share by Region (2027–2032)
Table 21. Global VMAT2 Inhibitor Revenue by Region (US$ Million), 2021–2026
Table 22. Global VMAT2 Inhibitor Revenue Market Share by Region (2021–2026)
Table 23. Global VMAT2 Inhibitor Revenue by Region (US$ Million), 2027–2032
Table 24. Global VMAT2 Inhibitor Revenue Market Share by Region (2027–2032)
Table 25. North America VMAT2 Inhibitor Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America VMAT2 Inhibitor Sales by Country (K Units), 2021–2026
Table 27. North America VMAT2 Inhibitor Sales by Country (K Units), 2027–2032
Table 28. North America VMAT2 Inhibitor Revenue by Country (US$ Million), 2021–2026
Table 29. North America VMAT2 Inhibitor Revenue by Country (US$ Million), 2027–2032
Table 30. Europe VMAT2 Inhibitor Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe VMAT2 Inhibitor Sales by Country (K Units), 2021–2026
Table 32. Europe VMAT2 Inhibitor Sales by Country (K Units), 2027–2032
Table 33. Europe VMAT2 Inhibitor Revenue by Country (US$ Million), 2021–2026
Table 34. Europe VMAT2 Inhibitor Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific VMAT2 Inhibitor Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific VMAT2 Inhibitor Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific VMAT2 Inhibitor Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific VMAT2 Inhibitor Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific VMAT2 Inhibitor Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America VMAT2 Inhibitor Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America VMAT2 Inhibitor Sales by Country (K Units), 2021–2026
Table 42. Latin America VMAT2 Inhibitor Sales by Country (K Units), 2027–2032
Table 43. Latin America VMAT2 Inhibitor Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America VMAT2 Inhibitor Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa VMAT2 Inhibitor Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa VMAT2 Inhibitor Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa VMAT2 Inhibitor Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa VMAT2 Inhibitor Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa VMAT2 Inhibitor Revenue by Country (US$ Million), 2027–2032
Table 50. Global VMAT2 Inhibitor Sales (K Units) by Type (2021–2026)
Table 51. Global VMAT2 Inhibitor Sales (K Units) by Type (2027–2032)
Table 52. Global VMAT2 Inhibitor Sales Market Share by Type (2021–2026)
Table 53. Global VMAT2 Inhibitor Sales Market Share by Type (2027–2032)
Table 54. Global VMAT2 Inhibitor Revenue (US$ Million) by Type (2021–2026)
Table 55. Global VMAT2 Inhibitor Revenue (US$ Million) by Type (2027–2032)
Table 56. Global VMAT2 Inhibitor Revenue Market Share by Type (2021–2026)
Table 57. Global VMAT2 Inhibitor Revenue Market Share by Type (2027–2032)
Table 58. Global VMAT2 Inhibitor Price (US$/Unit) by Type (2021–2026)
Table 59. Global VMAT2 Inhibitor Price (US$/Unit) by Type (2027–2032)
Table 60. Global VMAT2 Inhibitor Sales (K Units) by Application (2021–2026)
Table 61. Global VMAT2 Inhibitor Sales (K Units) by Application (2027–2032)
Table 62. Global VMAT2 Inhibitor Sales Market Share by Application (2021–2026)
Table 63. Global VMAT2 Inhibitor Sales Market Share by Application (2027–2032)
Table 64. Global VMAT2 Inhibitor Revenue (US$ Million) by Application (2021–2026)
Table 65. Global VMAT2 Inhibitor Revenue (US$ Million) by Application (2027–2032)
Table 66. Global VMAT2 Inhibitor Revenue Market Share by Application (2021–2026)
Table 67. Global VMAT2 Inhibitor Revenue Market Share by Application (2027–2032)
Table 68. Global VMAT2 Inhibitor Price (US$/Unit) by Application (2021–2026)
Table 69. Global VMAT2 Inhibitor Price (US$/Unit) by Application (2027–2032)
Table 70. Bausch Health Company Information
Table 71. Bausch Health Description and Business Overview
Table 72. Bausch Health VMAT2 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Bausch Health VMAT2 Inhibitor Product
Table 74. Bausch Health Recent Developments/Updates
Table 75. Teva Company Information
Table 76. Teva Description and Business Overview
Table 77. Teva VMAT2 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Teva VMAT2 Inhibitor Product
Table 79. Teva Recent Developments/Updates
Table 80. Neurocrine Biosciences Company Information
Table 81. Neurocrine Biosciences Description and Business Overview
Table 82. Neurocrine Biosciences VMAT2 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Neurocrine Biosciences VMAT2 Inhibitor Product
Table 84. Neurocrine Biosciences Recent Developments/Updates
Table 85. Hetero Company Information
Table 86. Hetero Description and Business Overview
Table 87. Hetero VMAT2 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Hetero VMAT2 Inhibitor Product
Table 89. Hetero Recent Developments/Updates
Table 90. Apotex Company Information
Table 91. Apotex Description and Business Overview
Table 92. Apotex VMAT2 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Apotex VMAT2 Inhibitor Product
Table 94. Apotex Recent Developments/Updates
Table 95. Actavis Laboratories Company Information
Table 96. Actavis Laboratories Description and Business Overview
Table 97. Actavis Laboratories VMAT2 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Actavis Laboratories VMAT2 Inhibitor Product
Table 99. Actavis Laboratories Recent Developments/Updates
Table 100. Mylan Company Information
Table 101. Mylan Description and Business Overview
Table 102. Mylan VMAT2 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Mylan VMAT2 Inhibitor Product
Table 104. Mylan Recent Developments/Updates
Table 105. Bionpharma Company Information
Table 106. Bionpharma Description and Business Overview
Table 107. Bionpharma VMAT2 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Bionpharma VMAT2 Inhibitor Product
Table 109. Bionpharma Recent Developments/Updates
Table 110. Dr. Reddy's Laboratories Company Information
Table 111. Dr. Reddy's Laboratories Description and Business Overview
Table 112. Dr. Reddy's Laboratories VMAT2 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Dr. Reddy's Laboratories VMAT2 Inhibitor Product
Table 114. Dr. Reddy's Laboratories Recent Developments/Updates
Table 115. Chartwell Pharmaceuticals Company Information
Table 116. Chartwell Pharmaceuticals Description and Business Overview
Table 117. Chartwell Pharmaceuticals VMAT2 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Chartwell Pharmaceuticals VMAT2 Inhibitor Product
Table 119. Chartwell Pharmaceuticals Recent Developments/Updates
Table 120. Sandoz Company Information
Table 121. Sandoz Description and Business Overview
Table 122. Sandoz VMAT2 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Sandoz VMAT2 Inhibitor Product
Table 124. Sandoz Recent Developments/Updates
Table 125. Sun Pharmaceutical Company Information
Table 126. Sun Pharmaceutical Description and Business Overview
Table 127. Sun Pharmaceutical VMAT2 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Sun Pharmaceutical VMAT2 Inhibitor Product
Table 129. Sun Pharmaceutical Recent Developments/Updates
Table 130. Lupin Company Information
Table 131. Lupin Description and Business Overview
Table 132. Lupin VMAT2 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Lupin VMAT2 Inhibitor Product
Table 134. Lupin Recent Developments/Updates
Table 135. Zydus Company Information
Table 136. Zydus Description and Business Overview
Table 137. Zydus VMAT2 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Zydus VMAT2 Inhibitor Product
Table 139. Zydus Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. VMAT2 Inhibitor Distributors List
Table 143. VMAT2 Inhibitor Customers List
Table 144. VMAT2 Inhibitor Market Trends
Table 145. VMAT2 Inhibitor Market Drivers
Table 146. VMAT2 Inhibitor Market Challenges
Table 147. VMAT2 Inhibitor Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of VMAT2 Inhibitor
Figure 2. Global VMAT2 Inhibitor Market Value by Type (US$ Million), 2021–2032
Figure 3. Global VMAT2 Inhibitor Market Share by Type: 2025 & 2032
Figure 4. Valbenazine Product Picture
Figure 5. Deutetrabenazine Product Picture
Figure 6. Tetrabenazine Product Picture
Figure 7. Global VMAT2 Inhibitor Market Value by Application (US$ Million), 2021–2032
Figure 8. Global VMAT2 Inhibitor Market Share by Application: 2025 & 2032
Figure 9. Chorea Caused by Huntington's Disease
Figure 10. Tardive Dyskinesia
Figure 11. Other
Figure 12. Global VMAT2 Inhibitor Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global VMAT2 Inhibitor Market Size (US$ Million), 2021–2032
Figure 14. Global VMAT2 Inhibitor Sales (K Units), 2021–2032
Figure 15. Global VMAT2 Inhibitor Average Price (US$/Unit), 2021–2032
Figure 16. VMAT2 Inhibitor Report Years Considered
Figure 17. VMAT2 Inhibitor Sales Share by Manufacturers in 2025
Figure 18. Global VMAT2 Inhibitor Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global VMAT2 Inhibitor Players: Market Share by Revenue in VMAT2 Inhibitor in 2025
Figure 20. VMAT2 Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global VMAT2 Inhibitor Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America VMAT2 Inhibitor Sales Market Share by Country (2021–2032)
Figure 23. North America VMAT2 Inhibitor Revenue Market Share by Country (2021–2032)
Figure 24. United States VMAT2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada VMAT2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe VMAT2 Inhibitor Sales Market Share by Country (2021–2032)
Figure 27. Europe VMAT2 Inhibitor Revenue Market Share by Country (2021–2032)
Figure 28. Germany VMAT2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France VMAT2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. VMAT2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy VMAT2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia VMAT2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific VMAT2 Inhibitor Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific VMAT2 Inhibitor Revenue Market Share by Region (2021–2032)
Figure 35. China VMAT2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan VMAT2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea VMAT2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India VMAT2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia VMAT2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan VMAT2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia VMAT2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America VMAT2 Inhibitor Sales Market Share by Country (2021–2032)
Figure 43. Latin America VMAT2 Inhibitor Revenue Market Share by Country (2021–2032)
Figure 44. Mexico VMAT2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil VMAT2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina VMAT2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia VMAT2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa VMAT2 Inhibitor Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa VMAT2 Inhibitor Revenue Market Share by Country (2021–2032)
Figure 50. Turkey VMAT2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia VMAT2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE VMAT2 Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of VMAT2 Inhibitor by Type (2021–2032)
Figure 54. Global Revenue Market Share of VMAT2 Inhibitor by Type (2021–2032)
Figure 55. Global VMAT2 Inhibitor Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of VMAT2 Inhibitor by Application (2021–2032)
Figure 57. Global Revenue Market Share of VMAT2 Inhibitor by Application (2021–2032)
Figure 58. Global VMAT2 Inhibitor Price (US$/Unit) by Application (2021–2032)
Figure 59. VMAT2 Inhibitor Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
